UNDINE The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine
- Coordinator
- Aarhus Universitet, Denmark
- Runs
- 1 June 2022 to 31 May 2026
- Status
- Running
- EU funding
- €6.7m
- Total cost
- €6.7m
- Partners
- 22 organisations in 13 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101057100
What the project is doing
In the project's own words, from its summary on CORDIS.
The consequences of SARS-CoV-2 exposure range from a lack of infection to lethal COVID-19. This immense inter-individual clinical variability is the key scientific and medical enigma in the field. While age and certain co-morbidities are known to influence disease outcome, these parameters do not explain all variation. In addition, there are other SARS-CoV-2 phenotypes of clinical importance: multisystem inflammatory syndrome in children and adults (MIS-C/A), and longCOVID.
An important breakthrough to unravel the pathogenesis of COVID-19 came from our two Science papers that were recognized by Nature among the top 10 discoveries of 2020. We found that about 4% of patients with critical COVID-19 pneumonia had inborn errors of immunity (IEI) that impair TLR3- and IRF7-dependent type I interferon (IFN) immunity and at least 10% of the patients carried pre-existing autoantibodies (auto-Abs) neutralizing type I IFNs.
These findings pave the way for further studies of COVID-19 pneumonia and other SARS-CoV-2 infection phenotypes and form the basis of the present research proposal, UNDINE, which follows a ""bed side to bench"" and ""bench to bed side"" approach, with the following objectivies i) to decipher the genetic and immunological basis of the various SARS-CoV-2 disease manifestations, to identify individuals at increased risk of critical COVID-19, post-infectious immunological complications, and vaccine failure iii) to develop ready-to-use diagnostic tests for large-scale detection of auto-Abs to type I IFNs and propose novel preventive and therapeutic approaches, based on the pathogenesis of SARS-CoV-2 infection for translation into personalised medicine.
To achieve these goals, our project will coordinate a European multidisciplinary and translational research effort relying on a strong and synergistic combination of assets, including unique cohorts from 11 EU countries and state-of-the art human genetic, immunological and virological expertises and technologies.""
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Aarhus Universitet | Aarhus C | Denmark | Coordinator |
| Katholieke Universiteit Leuven | Leuven | Belgium | Participant |
| Centre Hospitalier Universitaire Vaudois | Lausanne | Switzerland | Associatedpartner |
| Ecole Polytechnique Federale De Lausanne | Lausanne | Switzerland | Associatedpartner |
| Deutsches Primatenzentrum GmbH | Gottingen | Germany | Participant |
| Aarhus Universitetshospital | Aarhus | Denmark | Participant |
| Tartu Ulikool | Tartu | Estonia | Participant |
| Idryma Iatroviologikon Ereunon Akademias Athinon | Athina | Greece | Participant |
| Fundacio Hospital Universitari Vall D'hebron - Institut De Recerca | Barcelona | Spain | Third party |
| Fundacio Institut D'investigacio Biomedica De Bellvitge | L'Hospitalet De Llobregat | Spain | Third party |
| Institut Catala De La Salut | Barcelona | Spain | Participant |
| Institut De Investigacio En Ciencies De La Salut Germans Trias I Pujol | Badalona Barcelona | Spain | Third party |
| Servicio Madrileno De Salud | Madrid | Spain | Participant |
| Biomerieux SA | Marcy-l'Etoile | France | Participant |
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Participant |
| Institut Pasteur | Paris | France | Participant |
| The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin | Dublin | Ireland | Participant |
| Ospedale San Raffaele SRL | Milano | Italy | Participant |
| Universita Degli Studi Di Roma Tor Vergata | Roma | Italy | Participant |
| Universitair Medisch Centrum Utrecht | Utrecht | Netherlands | Participant |
| Karolinska Institutet | Stockholm | Sweden | Participant |
| Imperial College of Science Technology and Medicine | London | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI